Viracta Therapeutics Aktie (A2QQRS

Chart der Viracta Therapeutics Aktie

Charttool öffnen

Aktuelle Nachrichten zu Viracta Therapeutics

Das berichten andere über Viracta Therapeutics

XOMA (XOMA) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DATEWednesday, March 18, 2026 at 8:00 a.m. ETCALL PARTICIPANTSChief Executive Officer — Owen HughesChief Investment Officer — Bradley SitkoChief...

Viracta Therapeutics Announces Wind Down of Operations

SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention...

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention...